A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate Cancer
Jean de la Rosette(Radboud University Nijmegen), Pilar Laguna(Istanbul Medipol University), Chi‐Ho Leung(Chinese University of Hong Kong), Rafael Sánchez-Salas(McGill University), Juán Casanova Ramón-Borja(Fundación Instituto Valenciano de Oncología), Jeremy Yuen‐Chun Teoh(Chinese University of Hong Kong), Chi‐Fai Ng(Chinese University of Hong Kong), Kai Zhang(Second Affiliated Hospital of Jilin University), José L. Domínguez-Escrig(Fundación Instituto Valenciano de Oncología), Éric Barret(Institute Mutualiste Montsouris), Theo de Reijke(Amsterdam UMC Location University of Amsterdam), Julia Bohr(Kliniken Essen-Mitte), Gordon Muir(King's College Hospital)
Cited by 16
Related Papers
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
|New England Journal of Medicine|2003|2k
The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: Indications, Complications, and Outcomes in 5803 Patients
|Journal of Endourology|2011|818
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
|European Urology|2008|617
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2022|267